Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions fromde novoCMML-Reference-Cited by-同舟云学术

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions fromde novoCMML

Published:2017-11-03 Issue:1 Volume:93 Page:65-73
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Patnaik Mrinal M.¹^ORCID,Vallapureddy Rangit¹,Yalniz Fevzi F.¹,Hanson Curtis A.²,Ketterling Rhett P.³,Lasho Terra L.¹,Finke Christy¹,Al-Kali Aref¹,Gangat Naseema¹^ORCID,Tefferi Ayalew¹^ORCID

Affiliation:

1. Division of Hematology; Mayo Clinic; Rochester Minnesota

2. Division of; Hematopathology, Mayo Clinic; Rochester Minnesota

3. Division of; Cytogenetics, Mayo Clinic; Rochester Minnesota

Funder

National Center for Advancing Translational Sciences

CTSA

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood.,2016

2. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients;Patnaik;Leukemia.,2014

3. Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia;Patnaik;Blood Cancer J.,2016

4. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management;Patnaik;Am J Hematol.,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Molecular Pathogenesis and Diagnosis of Chronic Myelomonocytic Leukemia;Advances in Molecular Pathology;2024-08

3. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management;American Journal of Hematology;2024-03-07

4. Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia;Journal of Hematology & Oncology;2023-08-03

5. Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML);Leukemia;2023-07-08